{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:49:48Z","timestamp":1790660988905,"version":"4.1.0"},"reference-count":167,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background. Cardiovascular disease is a frequent complication after kidney transplantation and represents the leading cause of mortality in this population. Material and Methods. We searched for the relevant articles in the National Institutes of Health library of medicine, transplant, cardiologic and nephrological journals. Results. The pathogenesis of cardiovascular disease in kidney transplant is multifactorial. Apart from non-modifiable risk factors, such as age, gender, genetic predisposition and ethnicity, several traditional and non-traditional modifiable risk factors contribute to its development. Traditional factors, such as diabetes, hypertension and dyslipidemia, may be present before and may worsen after transplantation. Immunosuppressants and impaired graft function may strongly influence the exacerbation of these comorbidities. However, in the last years, several studies showed that many other cardiovascular risk factors may be involved in kidney transplantation, including hyperuricemia, inflammation, low klotho and elevated Fibroblast Growth Factor 23 levels, deficient levels of vitamin D, vascular calcifications, anemia and poor physical activity and quality of life. Conclusions. The timely and effective treatment of time-honored and recently discovered modifiable risk factors represent the basis of the prevention of cardiovascular complications in kidney transplantation. Reduction of cardiovascular risk can improve the life expectancy, the quality of life and the allograft function and survival.<\/jats:p>","DOI":"10.3390\/jpm12081200","type":"journal-article","created":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T22:49:02Z","timestamp":1658702942000},"page":"1200","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9254-618X","authenticated-orcid":false,"given":"Francesco","family":"Reggiani","sequence":"first","affiliation":[{"name":"Nephrology and Dialysis Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6060-965X","authenticated-orcid":false,"given":"Claudio","family":"Ponticelli","sequence":"additional","affiliation":[{"name":"Independent Investigator, 20131 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ki.2014.335","article-title":"Cardiovascular risk assessment in kidney transplantation","volume":"87","author":"Hart","year":"2015","journal-title":"Kidney Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1159\/000495081","article-title":"Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996\u20132014)","volume":"48","author":"Awan","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/TP.0000000000003224","article-title":"Cardiac mortality in kidney transplant patients: A population-based cohort study 1988\u20132013 in Australia and New Zealand","volume":"105","author":"Wyld","year":"2021","journal-title":"Transplantation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/tri.12413","article-title":"Cardiovascular morbidity and mortality after kidney transplantation","volume":"28","author":"Stoumpos","year":"2015","journal-title":"Transpl. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.23876\/j.krcp.18.0068","article-title":"Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study","volume":"38","author":"Jeon","year":"2019","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ndt\/gfz053","article-title":"Cardiovascular disease in the kidney transplant recipient: Epidemiology, diagnosis and management strategies","volume":"34","author":"Rangaswami","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41574-018-0137-7","article-title":"Post-transplant diabetes mellitus in patients with solid organ transplants","volume":"15","author":"Jenssen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000514288","article-title":"Post-transplant diabetes mellitus and prediabetes in renal transplant recipients: An update","volume":"145","author":"Porrini","year":"2021","journal-title":"Nephron"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.12850","article-title":"Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions","volume":"14","author":"Sharif","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc22-Sint","article-title":"Introduction: Standards of Medical Care in Diabetes\u20142022","volume":"45","author":"Association","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1210\/er.2015-1084","article-title":"Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes","volume":"37","author":"Shivaswamy","year":"2016","journal-title":"Endocr. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Beaupere, C., Liboz, A., F\u00e8ve, B., Blondeau, B., and Guillemain, G. (2021). Molecular mechanisms of glucocorticoid-induced insulin resistance. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020623"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Li, J.X., and Cummins, C.L. (2022). Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions. Nat. Rev. Endocrinol., 1\u201318.","DOI":"10.1038\/s41574-022-00683-6"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1476-5381.2010.01018.x","article-title":"Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells","volume":"162","author":"Smidt","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cpt.546","article-title":"Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus","volume":"101","author":"Chakkera","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ekir.2018.07.009","article-title":"Randomized controlled trial assessing the impact of tacrolimus versus cyclosporine on the incidence of posttransplant diabetes mellitus","volume":"3","author":"Torres","year":"2018","journal-title":"Kidney Int. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/ajt.14323","article-title":"Deciphering Tacrolimus-Induced Toxicity in Pancreatic \u03b2 Cells","volume":"17","author":"Wagner","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Li, Z., Sun, F., Zhang, Y., Chen, H., He, N., Chen, H., Song, P., Wang, Y., Yan, S., and Zheng, S. (2015). Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143405"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41419-019-1822-8","article-title":"Fasting and rapamycin: Diabetes versus benevolent glucose intolerance","volume":"10","author":"Blagosklonny","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12011-019-01922-0","article-title":"Role of magnesium in type 2 diabetes mellitus","volume":"196","author":"Feng","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1526924816633949","article-title":"New-onset diabetes after kidney transplantation and pretransplant hypomagnesemia","volume":"26","author":"Sinangil","year":"2016","journal-title":"Prog. Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/tri.13783","article-title":"Management of post-transplant diabetes: Immunosuppression, early prevention, and novel antidiabetics","volume":"34","author":"Hecking","year":"2021","journal-title":"Transpl. Int."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Corremans, R., Vervaet, B.A., D\u2019Haese, P.C., Neven, E., and Verhulst, A. (2019). Metformin: A candidate drug for renal diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010042"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1186\/cc13054","article-title":"Risk of developing severe sepsis after acute kidney injury: A population-based cohort study","volume":"17","author":"Lai","year":"2013","journal-title":"Crit. Care"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Gunaratne, K., Austin, E., and Wu, P.E. (2018). Unintentional sulfonylurea toxicity due to a drug\u2013drug interaction: A case report. BMC Res. Notes, 11.","DOI":"10.1186\/s13104-018-3404-8"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S2213-8587(19)30180-9","article-title":"Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: An analysis from the DECLARE\u2013TIMI 58 randomised trial","volume":"7","author":"Mosenzon","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcjd.2021.06.003","article-title":"Use of Sodium-Glucose Cotransporter-2 Inhibitors in Renal Transplant Patients With Diabetes: A Brief Review of the Current Literature","volume":"46","author":"Shuster","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/dc19-0093","article-title":"Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus","volume":"42","author":"Halden","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/ajt.15223","article-title":"Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety","volume":"19","author":"Schwaiger","year":"2019","journal-title":"Am. J. Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chewcharat, A., Prasitlumkum, N., Thongprayoon, C., Bathini, T., Medaura, J., Vallabhajosyula, S., and Cheungpasitporn, W. (2020). Efficacy and safety of SGLT-2 inhibitors for treatment of diabetes mellitus among kidney transplant patients: A systematic review and meta-analysis. Med. Sci., 8.","DOI":"10.3390\/medsci8040047"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ckj\/sfab131","article-title":"Management of post-transplant diabetes mellitus: An opportunity for novel therapeutics","volume":"15","author":"Montero","year":"2022","journal-title":"Clin. Kidney J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2337\/dc15-2383","article-title":"GLP-1 restores altered insulin and glucagon secretion in posttransplantation diabetes","volume":"39","author":"Halden","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.2337\/diabetes.51.2007.S434","article-title":"The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion","volume":"51","author":"MacDonald","year":"2002","journal-title":"Diabetes"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"617638","DOI":"10.1155\/2014\/617638","article-title":"Efficacy and safety of sitagliptin for the treatment of new-onset diabetes after renal transplantation","volume":"2014","author":"Boerner","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.2337\/dc11-s231","article-title":"Long-acting glucagon-like peptide 1 receptor agonists: A review of their efficacy and tolerability","volume":"34","author":"Garber","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","article-title":"Hypertension and cardiovascular risk: General aspects","volume":"129","author":"Kjeldsen","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11906-021-01139-4","article-title":"Hypertension in Kidney Transplant Recipients: Where Are We Today?","volume":"23","author":"Ari","year":"2021","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fped.2017.00086","article-title":"Hypertension in the pediatric kidney transplant recipient","volume":"5","author":"Charnaya","year":"2017","journal-title":"Front. Pediatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2014080834","article-title":"Assessment and management of hypertension in transplant patients","volume":"26","author":"Weir","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fmed.2020.00229","article-title":"Approach and Management of Hypertension After Kidney Transplantation","volume":"7","author":"Tantisattamo","year":"2020","journal-title":"Front. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1681\/ASN.2013040435","article-title":"BP, cardiovascular disease, and death in the folic acid for vascular outcome reduction in transplantation trial","volume":"25","author":"Carpenter","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/TP.0000000000002440","article-title":"Pulse Pressure and Outcome in Kidney Transplantation: Results From the Collaborative Transplant Study","volume":"103","author":"Opelz","year":"2019","journal-title":"Transplantation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/ndt\/gfn004","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: Three-year observational results","volume":"23","author":"Margreiter","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00007890-200203150-00021","article-title":"A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years1","volume":"73","author":"Vincenti","year":"2002","journal-title":"Transplantation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"ref_47","first-page":"167","article-title":"Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension","volume":"66","author":"Kopkan","year":"2017","journal-title":"Physiol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/HJH.0b013e32833c20eb","article-title":"Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity","volume":"28","author":"Klein","year":"2010","journal-title":"J. Hypertens."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5301\/jn.5000174","article-title":"Pathogenesis of calcineurin inhibitor-induced hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J. Nephrol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"E295","DOI":"10.1503\/cmaj.191012","article-title":"Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: A population-based cohort study","volume":"192","author":"Mebrahtu","year":"2020","journal-title":"CMAJ"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181c518cc","article-title":"Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis","volume":"89","author":"Knight","year":"2010","journal-title":"Transplantation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/ajkd.1998.v31.pm9428466","article-title":"Renal artery stenosis in kidney transplants","volume":"31","author":"Fervenza","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_53","first-page":"1030","article-title":"Overlooked Cause of Resistant Hypertension in a New Kidney","volume":"3","author":"Tantasattamo","year":"2015","journal-title":"Ann. Clin. Exp. Hypertens."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/ckj\/sfu132","article-title":"Transplant renal artery stenosis: Clinical manifestations, diagnosis and therapy","volume":"8","author":"Chen","year":"2015","journal-title":"Clin. Kidney J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ajh\/3.9.721","article-title":"Post-transplant hypertension","volume":"3","author":"Laskow","year":"1990","journal-title":"Am. J. Hypertens."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Costa, B., Moratelli, L., Silva, L.B., Paiva, A.C.M., Silva, A.N., Carminatti, M., Bastos, M., and Sanders-Pinheiro, H. (2014). Body mass index in the first year after kidney transplantation. Transplantation Proceedings, Elsevier.","DOI":"10.1016\/j.transproceed.2014.05.021"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.trre.2018.06.002","article-title":"Hypertension guidelines: How do they apply to kidney transplant recipients","volume":"32","author":"Aziz","year":"2018","journal-title":"Transplant. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000355135","article-title":"Are Thiazide Diuretics Safe and Effective Antihypertensive Therapy in Kidney Transplant Recipients?","volume":"38","author":"Taber","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MNH.0000000000000657","article-title":"Novel approaches to management of hyperkalaemia in kidney transplantation","volume":"30","author":"Rizk","year":"2021","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1592\/phco.23.6.788.32180","article-title":"Calcium channel blockers as the treatment of choice for hypertension in renal transplant recipients: Fact or fiction","volume":"23","author":"Baroletti","year":"2003","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kjms.2017.07.007","article-title":"Effect of renin-angiotensin system inhibitors on survival in kidney transplant recipients: A systematic review and meta-analysis","volume":"34","author":"Jiang","year":"2018","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/ndt\/gfy065","article-title":"Mineralocorticoid receptor antagonists in kidney transplantation: Time to consider?","volume":"33","author":"Girerd","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e000091","DOI":"10.1161\/JAHA.112.000091","article-title":"Beta and Angiotensin Blockades Are Associated With Improved 10-Year Survival in Renal Transplant Recipients","volume":"2","author":"Aftab","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"171S","DOI":"10.1016\/S0895-7061(01)02085-4","article-title":"Role of \u03b12-adrenergic receptors in hypertension","volume":"14","author":"Gavras","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ki.1989.157","article-title":"Post-transplant hypertension in the rat: Effects of captopril and native nephrectomy","volume":"36","author":"Coffman","year":"1989","journal-title":"Kidney Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijscr.2015.08.001","article-title":"Bilateral native nephrectomy for refractory hypertension in kidney transplant and kidney pancreas transplant patients","volume":"15","author":"Lerman","year":"2015","journal-title":"Int. J. Surg. Case Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/TP.0000000000002093","article-title":"Superior hypertension management in pediatric kidney transplant patients after native nephrectomy","volume":"102","author":"Brubaker","year":"2018","journal-title":"Transplantation"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/TP.0b013e318160254f","article-title":"Risk Factors for Cardiovascular Events After Successful Renal Transplantation","volume":"85","author":"Vanrenterghem","year":"2008","journal-title":"Transplantation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"58","DOI":"10.20452\/pamw.3269","article-title":"Beneficial effect of bilateral native nephrectomy as complete denervation on left ventricular mass and function in renal transplant recipients","volume":"126","author":"Obremska","year":"2016","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/HJH.0b013e32834bd1e7","article-title":"Pathogenesis and management of hypertension after kidney transplantation","volume":"29","author":"Chatzikyrkou","year":"2011","journal-title":"J. Hypertens."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ckj\/sfu134","article-title":"Renal denervation of the native kidneys for drug-resistant hypertension after kidney transplantation","volume":"8","author":"Dobrowolski","year":"2015","journal-title":"Clin. Kidney J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ajh\/hpt291","article-title":"Successful renal artery denervation in a renal transplant recipient with refractory hypertension","volume":"27","author":"Protasiewicz","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/ndt\/gfv311","article-title":"Impact of sympathetic renal denervation: A randomized study in patients after renal transplantation (ISAR-denerve)","volume":"30","author":"Schneider","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2215\/CJN.09310819","article-title":"Metabolic disorders with kidney transplant","volume":"15","author":"Cohen","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40620-018-0549-4","article-title":"Cardiovascular risk in renal transplant recipients","volume":"32","author":"Devine","year":"2019","journal-title":"J. Nephrol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5500\/wjt.v6.i1.125","article-title":"Post-transplant dyslipidemia: Mechanisms, diagnosis and management","volume":"6","author":"Agarwal","year":"2016","journal-title":"World J. Transplant."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-199702150-00001","article-title":"Hyperlipidemia in solid organ transplantation","volume":"63","author":"Kobashigawa","year":"1997","journal-title":"Transplantation"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Th\u00f6lking, G., Schulte, C., Jehn, U., Sch\u00fctte-N\u00fctgen, K., Pavenst\u00e4dt, H., Suwelack, B., and Reuter, S. (2021). The tacrolimus metabolism rate and dyslipidemia after kidney transplantation. J. Clin. Med., 10.","DOI":"10.3390\/jcm10143066"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/ATVBAHA.115.307030","article-title":"Low-Density Lipoprotein Receptor\u2013Dependent and Low-Density Lipoprotein Receptor\u2013Independent Mechanisms of Cyclosporin A\u2013Induced Dyslipidemia","volume":"36","author":"Kockx","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2014.12.017","article-title":"On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects","volume":"238","author":"Tavori","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Badiou, S., Garrigue, V., Dupuy, A.M., Chong, G., Cristol, J.P., and Mourad, G. (2006). Small dense low-density lipoprotein in renal transplant recipients: A potential target for prevention of cardiovascular complications. Transplantation Proceedings, Elsevier.","DOI":"10.1016\/j.transproceed.2006.07.003"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/TP.0b013e3181aa7d04","article-title":"Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations","volume":"88","author":"Tory","year":"2009","journal-title":"Transplantation"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12265-016-9719-8","article-title":"Sirolimus therapy is associated with elevation in circulating PCSK9 levels in cardiac transplant patients","volume":"10","author":"Simha","year":"2017","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40620-017-0378-x","article-title":"Renin-angiotensin system inhibitors in kidney transplantation: A benefit-risk assessment","volume":"30","author":"Ponticelli","year":"2017","journal-title":"J. Nephrol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40265-022-01691-6","article-title":"Contemporary Management of Dyslipidemia","volume":"82","author":"Ferraro","year":"2022","journal-title":"Drugs"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e13594","DOI":"10.1111\/eci.13594","article-title":"Statin use and incident cardiovascular events in renal transplant recipients","volume":"51","author":"Anderson","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2012.07.049","article-title":"Effects of fibrates in kidney disease: A systematic review and meta-analysis","volume":"60","author":"Jun","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14740338.2020.1732921","article-title":"Treatment of dyslipidemia in kidney transplantation","volume":"19","author":"Ponticelli","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.tp.0000203167.77570.11","article-title":"Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors","volume":"81","author":"Langone","year":"2006","journal-title":"Transplantation"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/eurjpc\/zwaa097","article-title":"Safety and efficacy of alirocumab in a real-life setting: The ODYSSEY APPRISE study","volume":"28","author":"Gaudet","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11883-021-00914-7","article-title":"ANGPTL3 and apolipoprotein C-III as novel lipid-lowering targets","volume":"23","author":"Akoumianakis","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Scheuermann, U., Babel, J., Pietsch, U.-C., Weimann, A., Lyros, O., Semmling, K., Hau, H.-M., and Seehofer, D. (2022). Recipient obesity as a risk factor in kidney transplantation. BMC Nephrol., 23.","DOI":"10.1186\/s12882-022-02668-z"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ags3.12049","article-title":"Obesity as a surgical risk factor","volume":"2","author":"Ri","year":"2018","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Lafranca, J.A., IJermans, J.N.M., Betjes, M.G.H., and Dor, F.J.M.F. (2015). Body mass index and outcome in renal transplant recipients: A systematic review and meta-analysis. BMC Med., 13.","DOI":"10.1186\/s12916-015-0340-5"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e31817ef0f9","article-title":"Obesity and cardiac risk after kidney transplantation: Experience at one center and comprehensive literature review","volume":"86","author":"Lentine","year":"2008","journal-title":"Transplantation"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1111\/j.1600-6143.2005.01073.x","article-title":"Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients","volume":"5","author":"Armstrong","year":"2005","journal-title":"Am. J. Transplant."},{"key":"ref_100","first-page":"439","article-title":"Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: A systematic review and meta-analysis","volume":"32","author":"Ladhani","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1111\/ajt.14258","article-title":"Filtration markers, cardiovascular disease, mortality, and kidney outcomes in stable kidney transplant recipients: The FAVORIT trial","volume":"17","author":"Foster","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2018.05.015","article-title":"Albuminuria and allograft failure, cardiovascular disease events, and all-cause death in stable kidney transplant recipients: A cohort analysis of the FAVORIT trial","volume":"73","author":"Weiner","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.kint.2017.01.028","article-title":"Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes","volume":"92","author":"Lam","year":"2017","journal-title":"Kidney Int."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/j.ajkd.2017.06.013","article-title":"Impact of hyperuricemia on long-term outcomes of kidney transplantation: Analysis of the FAVORIT study","volume":"70","author":"Kalil","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.kint.2020.05.056","article-title":"Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease","volume":"98","author":"Ponticelli","year":"2020","journal-title":"Kidney Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","article-title":"Definition of hyperuricemia and gouty conditions","volume":"26","author":"Bardin","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(20)32234-0","article-title":"Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): A multicentre, prospective, randomised, open-label, non-inferiority trial","volume":"396","author":"Mackenzie","year":"2020","journal-title":"Lancet"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jcpt.12794","article-title":"Comparison of efficacy and safety between febuxostat and allopurinol in early post-renal transplant recipients with new onset of hyperuricemia","volume":"44","author":"Shen","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1592\/phco.30.6.594","article-title":"Urate-lowering therapy for gout: Focus on febuxostat","volume":"30","author":"Love","year":"2010","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/ndt\/gfl044","article-title":"Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?","volume":"21","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1681\/ASN.2004070576","article-title":"Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: A prospective study","volume":"16","author":"Winkelmayer","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: Primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"123","author":"Bostom","year":"2011","journal-title":"Circulation"},{"key":"ref_113","first-page":"CD007910","article-title":"Interventions for lowering plasma homocysteine levels in kidney transplant recipients","volume":"4","author":"Kang","year":"2015","journal-title":"Cochrane Database Syst. Rev"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6651367","DOI":"10.1155\/2021\/6651367","article-title":"Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation","volume":"2021","author":"Wojtaszek","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa022600","article-title":"Soluble CD40 ligand in acute coronary syndromes","volume":"348","author":"Heeschen","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/3982","article-title":"Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes","volume":"4","author":"Hancock","year":"1998","journal-title":"Nat. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3389\/fimmu.2020.01807","article-title":"Coagulation and fibrinolysis in kidney graft rejection","volume":"11","author":"Stallone","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000452880","article-title":"Klotho\/FGF23 axis in chronic kidney disease and cardiovascular disease","volume":"3","author":"Lu","year":"2017","journal-title":"Kidney Dis."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Thongprayoon, C., Neyra, J.A., Hansrivijit, P., Medaura, J., Leeaphorn, N., Davis, P.W., Kaewput, W., Bathini, T., Salim, S.A., and Chewcharat, A. (2020). Serum klotho in living kidney donors and kidney transplant recipients: A meta-analysis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061834"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ki.2015.21","article-title":"Inflammation and hypoxia linked to renal injury by CCAAT\/enhancer-binding protein \u03b4","volume":"88","author":"Yamaguchi","year":"2015","journal-title":"Kidney Int."},{"key":"ref_121","first-page":"3810","article-title":"Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition","volume":"117","author":"Higgins","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jcmm.13060","article-title":"Signalling pathways involved in hypoxia-induced renal fibrosis","volume":"21","author":"Liu","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.kint.2021.04.016","article-title":"The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation","volume":"100","author":"Ponticelli","year":"2021","journal-title":"Kidney Int."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/0886022X.2011.649658","article-title":"Time-Course Evaluation of Oxidative Stress-Related Biomarkers after Renal Transplantation","volume":"34","author":"Schneiderka","year":"2012","journal-title":"Ren. Fail."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1570161115666170310092202","article-title":"Klotho-FGF23, cardiovascular disease, and vascular calcification: Black or white?","volume":"16","author":"Cianciolo","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-14-0457","article-title":"Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients","volume":"172","author":"Bleskestad","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/1744-9987.13578","article-title":"Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients","volume":"25","author":"Shikida","year":"2021","journal-title":"Ther. Apher. Dial."},{"key":"ref_128","first-page":"253","article-title":"Klotho: A Promising Biomarker Closely Related to Kidney Transplant","volume":"16","author":"Deng","year":"2018","journal-title":"Exp. Clin. Transplant. Off. J. Middle East Soc. Organ Transplant."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40620-014-0089-5","article-title":"Soluble Klotho levels in adult renal transplant recipients are modulated by recombinant human erythropoietin","volume":"27","author":"Leone","year":"2014","journal-title":"J. Nephrol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Podest\u00e0, M.A., Cucchiari, D., Ciceri, P., Messa, P., Torregrosa, J.V., and Cozzolino, M. (2021). Cardiovascular calcifications in kidney transplant recipients. Nephrol. Dial. Transplant., gfab053.","DOI":"10.1093\/ndt\/gfab053"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ndt\/gfv081","article-title":"Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: Potential partners in vascular calcifications","volume":"30","author":"Morena","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Sotomayor, C.G., te Velde-Keyzer, C.A., de Borst, M.H., Navis, G.J., and Bakker, S.J.L. (2020). Lifestyle, inflammation, and vascular calcification in kidney transplant recipients: Perspectives on long-term outcomes. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061911"},{"key":"ref_133","first-page":"1566","article-title":"Prognostic value of bone-and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: A systematic review and meta-analysis","volume":"32","author":"Pichler","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1681\/ASN.2014070670","article-title":"Calcification propensity and survival among renal transplant recipients","volume":"27","author":"Keyzer","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11033-020-06086-y","article-title":"An update on vascular calcification and potential therapeutics","volume":"48","author":"Singh","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"F618","DOI":"10.1152\/ajprenal.00278.2020","article-title":"Vitamin K deficiency: An emerging player in the pathogenesis of vascular calcification and an iatrogenic consequence of therapies in advanced renal disease","volume":"319","author":"Levy","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1111\/ajt.16566","article-title":"The ViKTORIES trial: A randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients","volume":"21","author":"Lees","year":"2021","journal-title":"Am. J. Transplant."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.amjmed.2018.11.005","article-title":"Effects of smoking on solid organ transplantation outcomes","volume":"132","author":"Anis","year":"2019","journal-title":"Am. J. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0085-2538(15)48744-7","article-title":"Risk factors for late kidney allograft failure","volume":"62","author":"Ponticelli","year":"2002","journal-title":"Kidney Int."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/TP.0b013e3182336095","article-title":"Effect of smoking on kidney transplant outcomes: Analysis of the United States Renal Data System","volume":"92","author":"Hurst","year":"2011","journal-title":"Transplantation"},{"key":"ref_141","first-page":"95","article-title":"Smoking Behaviors of Renal Transplant Recipients: An Analysis of 113 Patients","volume":"14","author":"Aydemir","year":"2016","journal-title":"Exp. Clin. Transplant. Off. J. Middle East Soc. Organ Transplant."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/ckj\/sfab072","article-title":"How to manage cigarette smoking in kidney transplant candidates and recipients?","volume":"14","author":"Devresse","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_143","first-page":"CD000146","article-title":"Nicotine replacement therapy versus control for smoking cessation","volume":"5","author":"Chepkin","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_144","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","volume":"4","author":"Howes","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ndt\/gfaa038","article-title":"Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients","volume":"35","author":"Kang","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.03340410","article-title":"Low physical activity and risk of cardiovascular and all-cause mortality in renal transplant recipients","volume":"6","author":"Zelle","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/ndt\/gfr434","article-title":"Influence of physical activity on cardiorespiratory fitness in children after renal transplantation","volume":"27","author":"Lubrano","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e13450","DOI":"10.1111\/ctr.13450","article-title":"Prehabilitation prior to kidney transplantation: Results from a pilot study","volume":"33","author":"Ying","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/j.ajkd.2017.12.005","article-title":"Physical activity in kidney transplant recipients: A review","volume":"72","author":"Takahashi","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Ponticelli, C., and Favi, E. (2021). Physical inactivity: A modifiable risk factor for morbidity and mortality in kidney transplantation. J. Pers. Med., 11.","DOI":"10.3390\/jpm11090927"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000496140","article-title":"Posttransplantation anemia in kidney transplant recipients","volume":"142","author":"Gafter","year":"2019","journal-title":"Acta Haematol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/ndt\/gfaa123","article-title":"Iron deficiency after kidney transplantation","volume":"36","author":"Vinke","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.hfc.2008.03.005","article-title":"Anemia and cardiovascular risk in the patient with kidney disease","volume":"4","author":"Fishbane","year":"2008","journal-title":"Heart Fail. Clin."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","article-title":"Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease","volume":"13","author":"Rigatto","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1016\/j.clnu.2020.12.025","article-title":"Vitamin D and cardiovascular health","volume":"40","author":"Vallecillo","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11154-017-9418-z","article-title":"Current evidence on vitamin D deficiency and kidney transplant: What\u2019s new?","volume":"18","author":"Sarno","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-3-319-56017-5_18","article-title":"Vitamin D, cardiovascular disease and risk factors","volume":"996","author":"Skaaby","year":"2017","journal-title":"Ultrav. Light Hum. Health Dis. Environ."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"207","DOI":"10.14797\/mdcj-15-3-207","article-title":"Vitamin D and calcium supplements: Helpful, harmful, or neutral for cardiovascular risk?","volume":"15","author":"Heravi","year":"2019","journal-title":"Methodist DeBakey Cardiovasc. J."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Sarhan, A.L., Jarareh, R.H., and Shraim, M. (2021). Quality of life for kidney transplant recipients and hemodialysis patients in Palestine: A cross-sectional study. BMC Nephrol., 22.","DOI":"10.1186\/s12882-021-02412-z"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5664\/jcsm.6542","article-title":"Depressive symptoms are associated with objectively measured sleep parameters in kidney transplant recipients","volume":"13","author":"Ronai","year":"2017","journal-title":"J. Clin. Sleep Med."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Burkhalter, H., Denhaerynck, K., Huynh-Do, U., Binet, I., Hadaya, K., De Geest, S., and Psychosocial Interest Group, Swiss Transplant Cohort Study (2017). Change of sleep quality from pre-to 3 years post-solid organ transplantation: The Swiss transplant cohort study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0185036"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/eurheartj\/ehl338","article-title":"Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146,538 participants in 54 observational studies","volume":"27","author":"Nicholson","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fpsyt.2016.00033","article-title":"Depression and the link with cardiovascular disease","volume":"7","author":"Dhar","year":"2016","journal-title":"Front. Psychiatry"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5500\/wjt.v2.i4.46","article-title":"Effects of exercise in renal transplant recipients","volume":"2","author":"Romano","year":"2012","journal-title":"World J. Transplant."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5664\/jcsm.27191","article-title":"Obstructive sleep apnea and cardiovascular disease: Role of the metabolic syndrome and its components","volume":"4","author":"Zizi","year":"2008","journal-title":"J. Clin. Sleep Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1378\/chest.11-1809","article-title":"Declining Kidney Function Increases the Prevalence of Sleep Apnea and Nocturnal Hypoxia","volume":"141","author":"Nicholl","year":"2012","journal-title":"Chest"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1159\/000513424","article-title":"Sleep Apnea as a Cardiorenal Risk Factor in CKD and Renal Transplant Patients","volume":"50","author":"Zoccali","year":"2021","journal-title":"Blood Purif."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/8\/1200\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:55:26Z","timestamp":1760140526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/8\/1200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":167,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["jpm12081200"],"URL":"https:\/\/doi.org\/10.3390\/jpm12081200","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,23]]}}}